Independent. Not owned by or funded by any pharmaceutical manufacturer.
Evidence-sourced · medically-reviewed where indicated
Dosing & administration

GLP-1 injection sites and rotation

Evidence-sourced
Written and fact-checked to our published editorial standards.Last updated 2026-07-24. Every clinical claim on this page is sourced to a named primary authority, listed at the foot of the page — see how we research, source, and correct our work.

Direct answer

What you need to know

Evidence strength: Strong

Into the fat just under the skin — abdomen, front of thigh, or back of the upper arm. Injectable GLP-1 medications are given subcutaneously, not into muscle. All three approved sites are considered equally effective, so choose what you can reach comfortably and rotate the exact spot each time to protect your skin.

Key takeaways

  • Three approved sites: abdomen, thigh, upper arm. No site works better than another.
  • Rotation is about skin, not absorption — repeatedly using one spot is what causes trouble.
  • Stay clear of the two inches around your navel, and of bruised or hardened skin.
  • Your product’s Instructions for Use governs technique; pens differ from each other.

Important limitation: This page describes what the approved labels have in common. It cannot substitute for the Instructions for Use that came with your specific pen, and it deliberately does not cover vials, syringes or any preparation step — those carry a different set of errors, covered on reconstitution and product identification.

Next action: Read the Instructions for Use in your pack once, properly, before your first injection — then use the rotation pattern below to decide where this week’s dose goes.

Primary sources: DailyMed — FDA labels, MedlinePlus

General education, not medical advice.

The three approved sites

Approved GLP-1 injection sites and a rotation patternA front-facing body outline showing three approved subcutaneous injection areas: the abdomen, avoiding a zone of about two inches around the navel; the front and outer upper thigh; and the back of the upper arm. Alongside it, a four-quadrant grid of the abdomen showing injection points rotated in sequence week to week.Abdomenstay ~2 in (5 cm) from the navelFront / outer thighupper leg, where there is fatBack of upper armusually needs another personRotate the exact spot each dose1234Week 1 → 2 → 3 → 4, then begin again.Keep repeat sites at least an inch apart.
The three approved subcutaneous injection areas, and a simple four-quadrant rotation pattern for the abdomen. The dashed circle marks the zone to avoid around the navel.Sites per the FDA prescribing information; the rotation pattern is our own illustration of the general principle.

How to rotate

Repeatedly injecting the exact same spot can cause the tissue under the skin to change — becoming lumpy, hardened, or thickened. Beyond being uncomfortable, injecting into altered tissue can affect how the medication is absorbed.

A simple, workable approach for a weekly medication:

Where not to inject

Basic technique

Pen designs differ meaningfully — some require attaching a needle and priming, others are pre-assembled single-dose devices. Follow the Instructions for Use in your product’s packaging, and ask your pharmacist to demonstrate the first time. The common principles:

Storage and disposal

Contact a healthcare professional if

  • An injection site becomes increasingly red, warm, swollen, or painful, or leaks pus — this may indicate infection.
  • You develop hard lumps or dents in the skin at sites you have used repeatedly.
  • You have a rash, hives, or swelling beyond the immediate injection area.
  • You are unsure whether a dose was delivered fully — ask before injecting again.
  • You experience swelling of the face, lips, tongue or throat, or difficulty breathing — seek emergency care.

For how injection timing fits into your overall schedule, see GLP-1 dosing and titration. For what to expect in the days after a dose, see our side-effect overview.

Sources

Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.

  1. FDA-approved prescribing information (drug labels)DailyMed, U.S. National Library of MedicineSupports: Approved subcutaneous injection sites and administration instructions per product.
  2. Patient drug and condition informationMedlinePlus, U.S. National Library of MedicineSupports: Patient-level guidance on subcutaneous injection technique.
  3. Drug approvals, labeling and safety communicationsU.S. Food & Drug AdministrationSupports: Guidance on safe sharps disposal.

This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.